Jeremy Hamm

ORCID: 0000-0002-0700-8641
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Advanced Radiotherapy Techniques
  • Head and Neck Cancer Studies
  • Breast Cancer Treatment Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Colorectal Cancer Screening and Detection
  • Gastric Cancer Management and Outcomes
  • Global Cancer Incidence and Screening
  • Lung Cancer Treatments and Mutations
  • Management of metastatic bone disease
  • Endometrial and Cervical Cancer Treatments
  • Breast Implant and Reconstruction
  • Medical Imaging Techniques and Applications
  • Advances in Oncology and Radiotherapy
  • Hormonal and reproductive studies
  • Economic and Financial Impacts of Cancer
  • Sarcoma Diagnosis and Treatment
  • Cervical Cancer and HPV Research
  • Brain Metastases and Treatment
  • Glioma Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment

BC Cancer Agency
2014-2024

University of British Columbia
2013-2021

CancerCare Manitoba
2016

Cancer Care Ontario
2009

University of Louisville
1992-2006

Arnold Palmer Hospital for Children
2002

United States Department of Veterans Affairs
1992

3 Background: This trial compared the efficacy of DE-EBRT and LDR-B for National Comprehensive Cancer Network (NCCN) high intermediate-risk disease. Methods: A planned sample size 400 patients were randomized to one two treatment arms stratified by risk group. Both received 12 months androgen deprivation therapy (ADT) with luteinizing hormone releasing (LHRH) agonist plus a non-steroidal anti-androgen at least 1 month. After 8 neo-adjuvant ADT, both whole pelvis EBRT (46Gy/23#). Patients...

10.1200/jco.2015.33.7_suppl.3 article EN Journal of Clinical Oncology 2015-03-01

Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does study add? Previous reports, with small numbers patients, have described problem incomplete testosterone suppression (>1.1 or 1.7 nmol/L) LHRH agonists. Various predisposing factors been suggested: different drug agents patient such as age, pretreatment levels weight. Such has shown in one report to be associated increased PSA failure rates another those metastases, worse survival. This used...

10.1111/j.1464-410x.2012.11190.x article EN BJU International 2012-05-07

In limited metastatic burden of disease, stereotactic body radiotherapy (SBRT) has been shown to achieve high local control rates. It hypothesized that SBRT may translate a better quality life by delaying the need for systemic chemotherapy and possibly increasing survival. There is published literature on efficacy in nodal metastases. The primary aim review institutional outcomes patients with solitary or oligometastatic lymph nodes treated SBRT. A retrospective study (March 2010–June 2015)...

10.1186/s13014-017-0820-1 article EN cc-by Radiation Oncology 2017-06-21

Background. Prior studies evaluating the effect of statins or acetylsalicylic acid (ASA) on survival men receiving prostate cancer were treatment have reported conflicting results, and not adjusted for comorbidity. Our aim is to investigate influence ASA survival, when comorbidity for, in treated with external beam radiation therapy (EBRT) cancer. Methods. A cohort 3851 patients curative EBRT ± androgen deprivation (ADT) between 2000 2007. Stage, treatment, medication use, Charlson index...

10.1155/2014/184297 article EN cc-by Prostate Cancer 2014-01-01

Introduction: Stereotactic ablative radiotherapy (SABR) is a relatively new technique for the curative-intent treatment of patients with inoperable early-stage non-small-cell lung cancer (NSCLC). Previous studies have demonstrated prognostic value positron emission tomography–computed tomography (PET/CT) parameters, including maximal standardized uptake (SUVmax), metabolic tumour volume (MTV), and total lesion glycolysis (TLG) in patients. We aimed to determine which pet/ct parameter most...

10.3747/co.26.4167 article EN cc-by Current Oncology 2019-02-01

This study examined whether sadness, but not anger, could facilitate adaptive goal disengagement capacity in the context of older adult's stress-related experiences. To this end, we investigated within-person effects sadness and anger on adults' were moderated by stress perceptions diurnal cortisol levels. In addition, tested an association between protect emotional well-being when adults experience higher than normal perceived or cortisol. The used data from a 6-wave 10-year longitudinal...

10.1037/emo0001091 article EN Emotion 2022-04-14

We used population-based data to identify incident cancer cases and correlates of among women living with HIV/AIDS in British Columbia (BC), Canada between 1994 2008.Data were obtained from a retrospective cohort created linkage two province-wide databases: (1) the database BC Cancer Agency, registry, (2) managed by Centre for Excellence HIV/AIDS, which contains on all persons treated antiretroviral therapy BC. This analysis included (≥ 19 years old) HIV BC, Canada. Incident diagnoses that...

10.1111/hiv.12290 article EN HIV Medicine 2015-08-12

No AccessJournal of UrologyAdult Urology11 Apr 2024Long Term Second Malignancies in Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy and Radical Prostatectomy Marie-Pier St-Laurent, George Acland, Sarah N. Hamilton, Jeremy Hamm, Katherine Sunderland, Peter C. Black, Michael McKenzie, Mira Keyes, Stacy Miller, Martin E. Gleave, Scott Tyldesley St-LaurentMarie-Pier St-Laurent https://orcid.org/0000-0002-7823-4857 , AclandGeorge Acland HamiltonSarah Hamilton HammJeremy Hamm...

10.1097/ju.0000000000003965 article EN The Journal of Urology 2024-04-11
Coming Soon ...